Skip to main content

5 Questions with TMC Innovation Institute Director Tom Luby

Published Apr 15, 2019 by Maggie Martin

 

TMC Innovation Institute

 

Tom Luby was recently named director of the Texas Medical Center Innovation Institute. Luby previously headed up JLABS @ TMC.

Below, Luby shares his priorities, what he's looking forward to most this year and how the institute fits in with the rest of Houston's innovation ecosystem. 

What are your priorities as Director of the Texas Medical Center Innovation Institute?

The Texas Medical Center’s goal is to serve its 61 [institution] members, and everything we do stems from that. At the TMC Innovation Institute, we’re focused on attracting companies from around the globe and showing them the value of establishing a presence in the largest medical city in the world. We want to work with those companies, open doors for them and provide them with solutions that will meet their needs.

We are continuing to build upon the success of TMC Biodesign, our fellowship program that unites the talents of innovators in order to quickly bring breakthrough products to market. And, of course, we will continue to grow our signature TMCx accelerator program, which provides startup companies with shared workspace, a curriculum for entrepreneurs and access to more than 200 advisors. We've had more than 250 companies come through the Innovation Institute that have received more than $900 million in funding, so we’re doing well. But I’m eager to add even more fuel to that fire. 

We also want to engage with corporate partners and believe it’s critical that major health care companies establish significant footprints in Houston. Importantly, we’re also working to bring more startup capital to Houston, which is critical to fostering the success of early-stage companies in Houston. 

What are the projects and initiatives you’re excited for most this year? 

This summer, we will open TMCxi at our John P. McGovern Campus on Holcombe Boulevard. It will be nearly 25,000 square feet of Class A office space that provides a turnkey solution for industry partners who seek to establish a presence in our growing health care ecosystem.

We see TMCxi as an amazing resource for technology companies, venture capitalists and others who want to be in the heart of the Texas Medical Center. It’s an important part of the TMC Innovation Institute, and we’re eager to welcome our new partners here. 

Why is innovation in health care—and at the TMC—so important? 

It’s important that we always remember: it’s all about the patients. We have a growing population of older adults, and we all know that end-of-life health care tends to be the most expensive. We need solutions that will provide people with the opportunity to live longer, healthier, high-quality lives, and hopefully prevent them from becoming long-term patients. 

When we talk about innovation, we often talk about devices, but we’re also talking about other forms of innovation. We want to see innovation in the way that health care is packaged and delivered too. Health care is expensive, and it needs to be more efficient. We think innovation means addressing those challenges as well. 

How does your organization fit into Houston as a growing innovation hub?

The TMC Innovation Institute is on the leading edge of Houston’s growing health care startup ecosystem. Our job is to enable our members to more efficiently turn their work in basic science and translational research into new products that will ultimately help patients. It’s also to connect our members to the startups that are developing the tools they need to continue providing world-class, cutting-edge health care. Additionally, our role is to recruit health care capital that can provide the crucial funding startups need to deliver on the promise of innovation.

We are engaging with large health care companies and showing them the tremendous value of establishing a presence in a place that’s home to 9,000-plus patient beds and some of the top researchers and clinicians from around the world. Importantly, we recognize that top talent has the opportunity to work anywhere, so we continue to play a key role in recruiting the world’s best to the Texas Medical Center.

The TMC Innovation Institute’s vision is “to become the global leader in health and life science innovation.” How do you envision meeting that goal?

We’re going to continue pushing to grow and develop that startup ecosystem here. We’ll be working with our member institutions to do that, as well as other partners in the startup space here in Houston. There is so much momentum right now. I think it’s increasingly clear to the world that if you’re a health care startup, you really need to have a foothold in the Texas Medical Center.

I keep saying this, but that’s because it’s so important. A big part of accomplishing our goals will require more and more startup capital to invest in early-stage companies in Houston. We’re putting our money where our mouth is and investing $25 million in early-stage companies through the TMC Venture Fund. It’s our job to continue drawing the talent here, and to show the value of investing in our ecosystem. If you’re a venture capitalist or corporate partner interested in what’s happening in our health care startup ecosystem — come see us. 

Related News

Life Sciences

One Year In, TMC’s Helix Park Proves to be a Powerful Innovation Hub

11/7/24
Nearly one year since launching its first phase, the Texas Medical Center’s Helix Park is already proving to be a powerful catalyst for innovation, attracting a range of life sciences companies and bolstering collaboration between industry and academia.   The 37-acre campus opened with the TMC3 Collaborative Building and Dynamic One Building, now home to prestigious institutions like Baylor College of Medicine, MD Anderson Cancer Center, Houston Methodist, Texas A&M University and UTHealth. Chicago-based venture capital firm Portal Innovations also joined the campus last year, occupying the entire third floor of the Collaborative Building with a 30,000-square-foot space.  Growth continues at Helix Park as local institutions and companies expand their research initiatives and establish a stronger presence on campus. Rice University recently launched RBL LLC, a venture creation studio designed to act as a direct pipeline for new companies built around the technologies developed at its Biotech Launch Pad, established last year.   “Leveraging Rice University’s Biotech Launch Pad breakthroughs and pairing it with the world-class translational infrastructure of TMC Helix Park well positions RBL to drive unprecedented advances in patient care,” said William McKeon, President and CEO of TMC, in a statement. “This partnership between academia, industry and health care is exactly what’s needed to transform medical discoveries into real-world solutions that improve lives globally.”  In September, March Biosciences, an emerging clinical-stage biotech company spun off from Baylor College of Medicine, Houston Methodist Hospital, and Texas Children’s Hospital’s Center for Cell and Gene Therapy, moved to the Helix Park campus. Shortly after the move, March Biosciences successfully closed an oversubscribed $28.4 million Series A financing round. This funding will support the Phase 2 clinical development of MB-105, the company’s innovative cancer-fighting therapy.   Switzerland-based biotech company Artidis also recently expanded to Helix Park, securing 2,000 square feet in Portal Innovations’ suite within the Collaborative Building, according to the Houston Business Journal. The company uses nanotechnology to rapidly diagnose cancer and develop personalized treatment plans.  MD Anderson Cancer Center is also increasing its footprint at TMC with a new $239 million, 281,254-square-foot research facility featuring lab and office space. According to the Houston Business Journal, the facility, set for completion in 2028, will focus on advancing preclinical research.  Additionally, the campus welcomed its first restaurant, Ojo de Agua, which offers a blend of Mexican and Mediterranean cuisine, contributing to Helix Park’s vision of becoming a premier destination.  “We are excited to introduce Ojo de Agua to the Texas Medical Center community and present a new spot where members and visitors can connect, celebrate and collaborate while enjoying a unique culinary experience,” said McKeon in a statement. “Food has a way of bringing people together and as our campus continues to welcome visitors from all over the world, Ojo de Agua will showcase high quality, fresh ingredients that reflect the vibrancy and diversity of our community.”  Learn more about the growth happening at TMC at the Partnership’s State of the Texas Medical Center event on November 14. 
Read More
Health Care

University of Houston, Baylor College of Medicine to Launch Cutting-Edge Research Hub

8/26/24
The University of Houston (UH) and Baylor College of Medicine (BCM) have been awarded a $44.2 million grant from the National Center for Advancing Translational Research. This funding will support the establishment of a regional hub dedicated to advancing clinical and translational research.  Dubbed the Consortium for Translational and Precision Health (CTPH), the new hub will enhance collaboration between the two institutions and other clinical and research groups within the Texas Medical Center. The CTPH aims to expedite the translation of new technologies and discoveries into patient care and real-world impact, provide funding and resources to accelerate pilot projects and research initiatives and connect investigators with local healthcare organizations and government agencies that are dedicated to healthcare, clinical research and policy.  “Research is the engine empowering health care’s life-changing advancements,” said UH President Renu Khator, in a release. “This innovative hub will be a catalyst for groundbreaking discoveries and treatments that improve people’s quality of life. That’s what drives us at UH and we’re ecstatic to cofound a regional hub for change alongside Baylor.”  The hub will be led by BCM’s Christopher Amos, professor and director of the Institute for Clinical and Translational Research, and Dr. Fasiha Kanwal, professor of medicine and chief of the section of gastroenterology and hepatology, alongside UH’s Dr. Bettina M. Beech, clinical professor of population health and chief population health officer.  “The CTPH is a partnership that draws on strengths of both institutions, creating a rich multidisciplinary environment. It will act as the vehicle to enhance the infrastructure and resources needed to effectively conduct research and implement solutions to advance healthcare,” said Dr. Carolyn Smith, interim senior vice president and dean of research at BCM. “It will help implement and create ongoing core research activities that will support the clinical translational science at both institutions.”  This strategic partnership comes at a time when local institutions are intensifying efforts to advance critical research that will deliver vital healthcare solutions. The University of Texas MD Anderson Cancer Center and Rice University recently announced a collaboration to advance fundamental and translational cancer research and develop life-saving technologies. Additionally, a research initiative led by Rice University, in collaboration with MD Anderson, received an $18 million grant to improve tumor removal technology for breast, head and neck cancer.  Learn more about Houston’s Life Sciences industry. 
Read More

Related Events

Economic Development

Houston's Advancements in Biotechnology

Join us for an insightful panel on the life science and biotechnology industry, where experts will dive into the latest trends, innovations, and transformative developments shaping the field. Our panelists, each…

Learn More
Learn More
Executive Partners